Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?

Patent foramen ovale (PFO) and cryptogenic stroke (CS) both have a high prevalence. The optimal treatment to reduce stroke recurrence after CS remains controversial. Results from clinical trials, meta-analyses, and position papers, support percutaneous PFO device closure and medical therapy compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrini, Iris, Cecchi, Enrico, Forno, Davide, Lyon, Alexander R, Asteggiano, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916420/
https://www.ncbi.nlm.nih.gov/pubmed/33664639
http://dx.doi.org/10.1093/eurheartj/suaa163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916420/
https://www.ncbi.nlm.nih.gov/pubmed/33664639
http://dx.doi.org/10.1093/eurheartj/suaa163

Ejemplares similares